Society Letters

Endocrine Society Comments on FDA Office of Women's Health Strategic Plan

September 02, 2020

To: Lowell Schiller and Dr. Kaveeta Vasisht

"The Endocrine Society appreciates the opportunity to comment on the strategic priorities of the Food and Drug Administration’s Office of Women’s Health (OWH). Founded in 1916, the Endocrine Society is the world’s oldest, largest, and most active organization devoted to research on hormones and the clinical practice of endocrinology. The Society’s membership of over 18,000 includes experts in all research and clinical aspects of hormone health, including women’s health and reproductive health.
We offer the recommendations below, which highlight areas of particular relevance to endocrine research and clinical practice. These recommendations are also shared by the Society for Women’s Health Research."

arrowRead the Full Comment Letter

Last Updated:
Take Action

Make Your Voice Heard

Take Action
We rely on your voice to advocate for our policy priorities. Join us to show our strength as a community that cares about endocrinology. Contact your U.S representatives or European Members of Parliament through our online platform. Take action and make a difference today.

We rely on your voice to advocate for our policy priorities. Join us to show our strength as a community that cares about endocrinology. Contact your U.S representatives or European Members of Parliament through our online platform. Take action and make a difference today.

Back to top

Who We Are

For 100 years, the Endocrine Society has been at the forefront of hormone science and public health. Read about our history and how we continue to serve the endocrine community.